Founder of mitochondrial genetics field to speak at IU
Douglas Wallace, PhD, MD (honoris causa), and his colleagues are widely recognized for founding the field of human mitochondrial genetics more than 35 years ago. Since then, his groundbreaking work has been reshaping the way scientists think about aging, disease and even the way our bodies respond to viruses like COVID-19. On Aug. 25, Wallace will share his work with the Indiana University School of Medicine community.
Pediatric cancer researcher explores novel treatments for solid tumors
The lab of Karen E. Pollok, PhD, bears the name of Caroline Symmes, who was just under 4 years old when she was diagnosed with metastatic Wilms
IU School of Medicine awarded prestigious grant to propel vision research
The Department of Ophthalmology has received funding that will help advance research and lead to innovative treatments.
Epigenetic marker may provide early detection for risk of preeclampsia-related preterm birth
IU School of Medicine researchers are studying how medical professionals can make a preeclampsia diagnosis earlier and more accurately.
Medical students to present research projects at summer symposium
The IU School of Medicine community is invited to learn more about medical students’ summer research projects at a July poster symposium on the Indianapolis
The Protein Folding Problem: The day AI unlocked a secret of life
This column is the second in a four-part series from Taeho Jo, titled "AI in Medicine: From Nobel Discoveries to Clinical Frontiers."
Basic science researcher blends academic, industry experience to lead Alzheimer's drug discovery efforts
Timothy Richardson is a research professor of medicine at the IU School of Medicine and helps lead the TREAT-AD drug discovery center.
Research space utilization highlight: Q&A with John Leck
John Leck is the director of space planning and utilization at the IU School of Medicine. He discusses his new role, background, and the importance
IU medical scientists, Purdue engineers meet at symposium to foster collaborative research
Scientists, physicians and engineers representing gathered to share groundbreaking work, raise important questions and plant the seeds of future research collaboration and innovation.
IU neurologist's research leads to first FDA-approved drug to treat neurofibromatosis type 1
Patients who participated in the clinical trial of the new therapy not only experienced reduction in NF1 and plexiform neurofibromas tumor volume, but also reported